SBBOS AND PEPTIC ULCER DISEASE: EPIDEMIOLOGY, PATHOGENESIS, INFLUENCE ON CLINICAL MANIFESTATIONS AND THERAPEUTIC APPROACHES
https://doi.org/10.21518/2079-701X-2017-15-56-60
Abstract
The paper discusses the main aspects of the pathogenesis and incidence of SBBOS in the small intestine in patients with peptic ulcer of the duodenum associated with persistence of H. pylori; the effect of SBBOS on clinical manifestations. Diagnosis was made using the hydrogen breathing test with lactulose. The study found that SBBOS in patients with peptic ulcer associated with H. pylor is found in 62% and modifies the clinical pattern, prolonging the symptoms of gastric dyspepsia, provokes development of symptoms of intestinal dyspepsia, requires longer duration of treatment to achieve remission (clinical and endoscopic). This is the basis for its treatment.
About the Authors
O. N. Minushkin
Central State Medical Academy of the Russian Federation President Affairs Management
Russian Federation
Russian Federation
MD, Prof.
Y. S. Skibina
Central State Medical Academy of the Russian Federation President Affairs Management
Russian Federation
Russian Federation
T. B. Topchiy
Central State Medical Academy of the Russian Federation President Affairs Management
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
N. V. Lvova
Central State Medical Academy of the Russian Federation President Affairs Management
Russian Federation
Russian Federation
References
1. Ардатская М.Д., Минушкин О.Н. Синдром избыточного бактериального роста: определение, современные подходы к диагностике и лечебной коррекции. Consillium Medicum. Гастроэнтерология, 2012, 2: 45-49.
2. Miazga A, Osinski M, Cichy W, Zaba R. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Advances in Medical Sciences, 2015 March, 60(1): 118–124.
3. Кучерявый Ю.А., Оганесян Т.С. Синдром избыточного бактериального роста. РЖГГК, 2010, 20(5): 63-68.
4. Белоусова Е.А. Синдром избыточного бактериального роста тонкой кишки в свете общей концепции о дисбактериозе кишечника. Взгляд на проблему. Фарматека, 2009, 2.
5. Carrara M, Desideri S, Azzurro M, Bulighin GM et al. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. Eur. Rev. Med. Pharmacol. Sci., 2008 May-Jun, 12(3): 197-202.
6. Lin H.C. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA, 2004 Aug 18, 292(7): 852-8.
7. Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther, 2009 Jun 15, 29(12): 1273-81.
8. Mancilla AC, Madrid AM, Hurtado HC, Orellana BC, Pena ZM, Tobar AE, et al. Sobrecrecimiento bacteriano intestinal en pacientes con pancreatitis cronica. Rev Med Chile, 2008, 136: 976–80.
9. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin, 1999, 15: 47–52.
10. Bures J, Cyrany J, Kohoutova D et al. Small intestinal bacterial overgrowth syndrome. Wld J. Gastroenterol., 2010, 28: 2978–2990.
11. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin. Gastroenterol. Hepatol., 2010 Jun, 8(6): 504-8.
12. Grace E, Shaw C, Whelan K & Andreyev HJN. Review article: small intestinal bacterial overgrowth – prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther, 2013 Oct, 38(7): 674-88.
13. Posserud I, Stotzer PO, Bjornsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut, 2007, 56: 802-808.
14. Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SSC. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther, 2013, 37: 1103–11.
15. Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest, 2010, 41: 380–6.
16. Singh VV, Toskes PP, Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment. Curr. Treat. Options. Gastroenterol., 2004, 7(1): 19–28.
17. Gasbarrini A, Lauritano EC, Gabrielli M et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig. Dis., 2007, 25: 237-240
18. Василенко В.В. Дисбактериоз – синдром раздраженного кишечника: эссе-анализ проблемы. Рос. журн. гастроэнтерол., гепатол., колопроктол., 2000, 6: 10–13.
19. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol, 2008, 103: 958–63.
20. Braden B. Methods and functions: Breath tests. Best Pract. Res. Clin. Gastroenterol., 2009, 23(3): 337-352.
21. Gasbarrini A, Corazza GR, Gasbarrini G et al. Methodology and indications of H2 breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment. Pharma col. Therapeut., 2009, 29(suppl. 1): 1-49.
22. Hamilton L.H. Breath tests and gastroenterology. 2nd ed. Milwaukee, WI, USA: Quintron Instrument company, 1998.
23. Передерий В.Г., Козлов В.А., Сизенко А.К., Швец О.В. Синдром избыточного бактериального роста: от микробиологии до лечения. Сучасна гастроентерологія, 2011, 1(57): 124–130.
24. Levitt MD, Bond JHJr. Volume, composition, and-source of intestinal gas. Gastroenterology, 1970, 59: 921–929.
25. Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J. Lab. Clin. Med., 1970, 75: 937–945.
26. Ibanez P, Pimentel M, Melmed GY, Ippoliti A. Fatigue and abdominal bloating predict small intestinal bacterial overgrowth in patients with ulcerative colitis [abstract]. Gastroenterology, 2008, 134: A-350.
27. G. M. Smith, I. M. Chesner, P. Asquith, and M. J. Leyland. Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia. Journal of Clinical Pathology, vol. 43, no. 1, pp. 57–59, 1990.
28. Chave JPJ, Thorens JJ, Frohlich FF, Gonvers JJJ, Glauser MPM, Bille JJ, et al. Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptoms. Am J Gastroenterol, 1994, 89: 2168–71.
29. Логинов В.А., Минушкин О.Н. Синдром избыточного бактериального роста: некоторые аспекты клиники и диагностики. Кремлевская медицина. Клинический вестник, 2013, 4.
30. Минушкин О.Н., Кручинина М.А. Синдром избыточного бактериального роста у больных дивертикулярной болезнью толстой кишки. Кремлевская медицина. Клинический вестник, 2014, 1.
Review
For citations:
Minushkin ON, Skibina YS, Topchiy TB, Lvova NV. SBBOS AND PEPTIC ULCER DISEASE: EPIDEMIOLOGY, PATHOGENESIS, INFLUENCE ON CLINICAL MANIFESTATIONS AND THERAPEUTIC APPROACHES. Meditsinskiy sovet = Medical Council. 2017;(15):56-60. (In Russ.) https://doi.org/10.21518/2079-701X-2017-15-56-60
Views:
675
Email this article 